Doctor profile · Federal record
Dr. Andrew Ip, M.D.
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Hackensack, NJ
- NPI 1306102934
- Accepts Medicare
- MIPS 79.9 / 100 · 2023
- 14 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
92 2Nd St
Hackensack, NJ 076012191
(551) 996-3033
fax (551) 996-0573
Credentials & registration
- NPI registered
- April 2012 — 14 yrs on file
- Profile last updated
- January 26, 2022
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New Jersey #25MA10621100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306102934. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
32,714
Distinct HCPCS
10
Medicare allowed
$314,652
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 30,540 | 13 | $0 | |
Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 792 | 25 | $135 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 563 | 181 | $195 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 364 | 167 | $138 | |
96372 |
Injection of drug or substance under skin or into muscle | 157 | 41 | $16 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 148 | 37 | $117 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 47 | 38 | $182 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 37 | 22 | $80 | |
99238 |
Hospital discharge day management, 30 minutes or less | 25 | 18 | $84 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 21 | $133 |
In context: peer comparison
Among 12 peers in Hackensack Medical Oncology Physician, average services per provider: 1,060. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$43,881
Transactions
36
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, INC. | 18 | $20,165.13 | |
| Abbvie INC. | 9 | $8,398.30 | |
| Pfizer INC. | 2 | $6,662.50 | |
| Genmab U.S., INC. | 5 | $6,558.60 | |
| Kite Pharma, INC. | 1 | $2,080.00 | |
| Celgene Corporation | 1 | $16.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
771
Patients
250
Total drug cost
$1,710,744
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 187 | 51 | $3,540 |
| Prednisone | Generic | 117 | 44 | $316 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 83 | 23 | $410 |
| Ciprofloxacin Hcl | Generic | 70 | 24 | $487 |
| Calquence (Acalabrutinib Maleate) | Brand | 57 | 0 | $859,114 |
| Fluconazole | Generic | 44 | 19 | $1,478 |
| Ondansetron Hcl | Generic | 34 | 24 | $260 |
| Revlimid (Lenalidomide) | Brand | 33 | 0 | $456,144 |
| Allopurinol | Generic | 32 | 22 | $260 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 29 | 11 | $2,008 |
Hospital affiliations
Frequently asked questions
What is Dr. Andrew Ip's medical specialty?
Dr. Andrew Ip practices Medical Oncology Physician in Hackensack, NJ.
Where does Dr. Andrew Ip practice?
Dr. Andrew Ip practices at 92 2Nd St, Hackensack, NJ 076012191. Office phone: 5519963033.
What is Dr. Andrew Ip's NPI?
Dr. Andrew Ip's National Provider Identifier (NPI) is 1306102934, issued by NPPES.
Does Dr. Andrew Ip accept Medicare assignment?
Yes. Dr. Andrew Ip accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Ip commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg (HCPCS Q5111); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.